U.S. Purchases 2 Million Doses of Game-Changing HIV Prevention Drug
The U.S. government will buy 2 million doses of lenacapavir, a long-acting HIV prevention injection, for distribution in low and middle-income countries through 2028. This bold step highlights renewed determination to slow HIV, particularly in regions where prevention has faced serious challenges. What Is Lenacapavir and Why Does It Matter Lenacapavir, created by Gilead Sciences,…